As for the pathogenesis of MM at the genetic level, mutations in BRAF and NRAS genes, genes that activate the RAS/mitogen-activated protein kinase (MAPK) pathway, are detected in approximately 40–50% and 15–20% of human MM cases, respectively [4]. The gene discussed is WNK2; the disease is Miyoshi myopathy.